News
Seattle Genetics Announces Approval For FDA Accepts Brentuximab Vedotin BLAs
Seattle Genetics, Inc. announced that the U.S. Food and Drug Administration has accepted for filing two Biologics License Applications (BLAs) for brentuximab vedotin, including one for the treatment of patients with relapsed or refractory Hodgkin lymphoma and one for...
News
Teva to Acquire Cephalon in $6.8 Billion Transaction
Teva Pharmaceutical Industries Ltd. and Cephalon, Inc.announced that their Boards of Directors have unanimously approved a definitive agreement under which Teva will acquire all of the outstanding shares of Cephalon for $81.50 per share in cash, or a total...
News
Ranbaxy Launches Generic Olanzapine Tablets in Spain
Ranbaxy Laboratories Limited announced the Day-1 launch of Olanzapine Tablets, the generic version of Zyprexa. Ranbaxy will be introducing Olanzapine tablets 2.5mg, 5mg, 7.5mg and 10mg and also orodispersables in 5mg and 10mg. Zyprexa is the innovator product of...
News
SGS Korea Lab becomes a Certified Body Technical Lab for Medical Devices
IEC System for Conformity Testing and Certification of Electrotechnical Equipment and Components CB Scheme and CB-FCS Scheme has accredited the SGS Korea testing lab as a Certified Body Technical Lab (CBTL) for Medical Devices and their relevant IEC standards....
News
Aurobindo Pharma receives final approval for Divalproex Sodium Delayed-Release Tablets
Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration to manufacture and market Divalproex Sodium Delayed - Release Tablets USP 125mg, 250mg and 500mg. ...
News
Thermo Fisher Scientific Introduces New Cell Assay for Predictive Liver Toxicity Testing
Thermo Fisher Scientific Inc., the world leader in serving science has introduced the ToxInsight DILI Assay Cartridge, a groundbreaking new tool for assessing the liver toxicity risk of chemical compounds. It will help pharmaceutical companies improve their productivity by...
News
Novartis completes merger with Alcon
Novartis announced that it completed the merger of Alcon, Inc. Â into Novartis. The completion of the merger follows the Novartis shareholders' approval of the merger, as well as the proposed capital increase at the company's Extraordinary Shareholder Meeting...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read